Kisspeptin: Complete Guide to Benefits, Dosage & Side Effects (2026)

Important: Kisspeptin is not approved by the FDA for any treatment and is sold in the US for laboratory research purposes only. This guide summarizes the available research — it is not medical advice, and the dose figures below are reported research ranges, not recommendations. It is not suitable for minors. Consult a licensed healthcare professional before using any research compound.

Kisspeptin sits further "upstream" than almost any other compound in this space. Most libido or testosterone products act on a single downstream target; kisspeptin acts on the master switch of the entire reproductive axis. That's what makes it scientifically interesting — and what makes the online hype so easy to overstate. This guide sticks to what the human research actually shows.

What is kisspeptin?#

Kisspeptin is a neuropeptide encoded by the KISS1 gene that signals through the receptor KISS1R (GPR54). It exists in several lengths cleaved from a common precursor — the two most commonly researched are kisspeptin-10 (KP-10) and kisspeptin-54 (KP-54). Discovered as "metastin" (a metastasis suppressor) before its reproductive role was understood, kisspeptin turned out to be a gatekeeper of puberty and fertility: people with inactivating KISS1R mutations fail to enter puberty (kisspeptin & KISS1R reproductive pathway review, PMC).

How kisspeptin works (the HPG axis)#

Kisspeptin works by stimulating GnRH (gonadotropin-releasing hormone) neurons in the hypothalamus. That triggers a cascade:

Kisspeptin → GnRH → LH & FSH (from the pituitary) → testosterone (men) / estrogen & ovulation (women)

The key distinction: kisspeptin acts above GnRH, using the body's own pulsatile signaling rather than bypassing it. In a landmark study, a single dose of kisspeptin-54 potently raised LH, FSH, and testosterone in healthy men (Dhillo et al., JCEM 2005). This "upstream" action is why it's contrasted with compounds like hCG (which mimics LH directly) — more on that below.

Kisspeptin benefits: what the research actually shows#

Here's where honesty matters. Kisspeptin has real, peer-reviewed human data in a few specific areas — and a lot of marketing claims that go well beyond it. We cover only what's supported.

Libido and sexual desire#

This is the most compelling human evidence. In a randomized, placebo-controlled study, kisspeptin administration enhanced activity in the brain's sexual and emotional processing centers and attenuated negative mood in healthy men (Comninos et al., JCI 2017). A later randomized clinical trial in men with hypoactive sexual desire disorder (HSDD) found kisspeptin boosted sexual brain processing and penile response versus placebo (JAMA Network Open 2023, PMC). The libido effect is the best-substantiated benefit.

Testosterone, LH and FSH in men#

Because kisspeptin drives the HPG axis, it raises LH and FSH, which in turn stimulate testosterone — demonstrated in healthy men after kisspeptin-54 administration (Dhillo et al., JCEM 2005). Importantly, it does this by stimulating natural production rather than replacing it, which is the mechanistic appeal for those researching it as an alternative to direct hormone replacement.

Fertility, ovulation and IVF#

In women, kisspeptin stimulates the gonadotropins that govern ovulation, and it has been studied as a trigger for egg maturation in IVF — with research interest centered on a lower risk of ovarian hyperstimulation than the standard hCG trigger (reproductive pathway review, PMC). This is an active clinical-research area, not an at-home application.

Mood and other early signals#

The same studies that mapped kisspeptin's sexual-processing effects also noted mood and reward modulation (Comninos et al., JCI 2017). Treat anything beyond libido, gonadotropin/testosterone, and fertility as preliminary. Claims that kisspeptin "prevents wrinkles," "boosts immunity," or "promotes weight loss" are not supported by the human literature — ignore them.

Kisspeptin dosage (research ranges)#

There is no approved kisspeptin dose — what follows is reported from research, not a protocol. Clinical studies have used both KP-10 and KP-54 by subcutaneous or intravenous routes, typically as a single bolus or short infusion rather than chronic daily use. Within the research community, reported subcutaneous research amounts cluster around ~100 mcg, sometimes titrated upward.

The single most important dosing finding is a caution, not a number: continuous, frequent administration causes tachyphylaxis — the receptor desensitizes and the effect fades. In women given chronic kisspeptin-54, the gonadotropin response diminished over time (Jayasena et al., JCEM 2009). This is why research protocols favor intermittent rather than constant exposure, and why "more, more often" is counterproductive. Use our reconstitution calculator to convert any target research dose into exact syringe units.

How to reconstitute kisspeptin#

Kisspeptin ships as a lyophilized powder and must be reconstituted with bacteriostatic water before measuring. A common research approach is to add BAC water to reach an easy-to-measure concentration (for a 10 mg vial, 2–3 mL gives 5–3.33 mg/mL). The exact volume determines your concentration and therefore your draw — see the step-by-step reconstitution guide and run your numbers through the calculator. Reconstitute gently (swirl, don't shake) and refrigerate.

Side effects and safety#

Kisspeptin has been reasonably well tolerated in short clinical studies, but long-term safety data in humans is limited, and the research-grade market is unregulated. Reported and plausible effects include:

• Flushing — the most commonly reported effect, seen in a substantial share of male subjects.
• Injection-site reactions — redness or irritation.
• Headache or nausea — occasional, usually transient.
• Hormonal shifts — because it drives the whole axis, sustained use can raise estradiol (via aromatization of increased testosterone) and disturb the natural feedback loop.
• Tachyphylaxis — frequent dosing blunts the response (Jayasena et al., JCEM 2009).

Who should avoid it: minors (kisspeptin governs pubertal timing), pregnant or breastfeeding women, and anyone with a hormone-sensitive condition. Because it modulates the reproductive axis, anyone on fertility, hormone, or psychiatric medication should involve a clinician.

Kisspeptin for men vs women#

Kisspeptin vs alternatives#

• vs hCG: HCG mimics LH directly at the testes; kisspeptin acts upstream on the brain to stimulate the body's own LH. Different mechanisms, different desensitization profiles.
• vs PT-141: PT-141 (bremelanotide) drives libido through melanocortin pathways and acts acutely on arousal; kisspeptin works through the reproductive-hormone axis. They target desire by completely different routes — see kisspeptin vs PT-141 discussions.
• vs GnRH/gonadorelin: GnRH analogs act one step downstream of kisspeptin; kisspeptin is the upstream trigger.

Results: what to expect#

Honestly: kisspeptin is not a "feel it in an hour" compound for most uses. The hormonal effects (LH/testosterone) occur within hours of dosing in studies but are transient; the libido/brain-processing effects were measured acutely in controlled settings. Because of tachyphylaxis, sustained daily self-administration tends to produce less effect over time, not more. The research framing — intermittent, low-dose, axis-stimulating — matters more than any "stack."

Where to buy kisspeptin#

Research-grade kisspeptin (usually a 10 mg KP-10 vial) is sold by research-chemical suppliers for laboratory use only. Quality varies, so a current COA and verified purity matter. Peptide Supply Co. is our top-rated source; compare live pricing below and see our full where to buy kisspeptin guide for vendor criteria.

Frequently asked questions